Relation of Change of Body Mass Index to Long-Term Mortality After Cardiac Catheterization.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 01 2020
Historique:
received: 28 08 2019
revised: 10 10 2019
accepted: 11 10 2019
pubmed: 20 11 2019
medline: 23 4 2020
entrez: 20 11 2019
Statut: ppublish

Résumé

Body-mass index (BMI) is a risk marker and therapeutic target in cardiovascular prevention. The effect of changes in BMI on mortality in patients with cardiovascular diseases has not been completely delineated. We aimed to assess the association between percent change in BMI, as measured 3-years after cardiac catheterization, and long-term mortality. Patients who underwent cardiac catheterization (n = 11,220; mean age 63 ± 10 years) were categorized according to BMI groups (normal-weight, 18.50 to 24.99 kg/m

Identifiants

pubmed: 31740019
pii: S0002-9149(19)31152-X
doi: 10.1016/j.amjcard.2019.10.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

270-276

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Barak Zafrir (B)

Department of Cardiology, Lady Davis Carmel Medical Center, Haifa, Israel; Faculty of Medicine, Technion, Israel institute of Medicine, Haifa, Israel. Electronic address: barakzmd@gmail.com.

Elad Shemesh (E)

Department of Cardiology, Lady Davis Carmel Medical Center, Haifa, Israel; Faculty of Medicine, Technion, Israel institute of Medicine, Haifa, Israel.

Dror B Leviner (DB)

Faculty of Medicine, Technion, Israel institute of Medicine, Haifa, Israel; Department of Cardiothoracic Surgery, Lady Davis Carmel Medical Center, Haifa, Israel.

Walid Saliba (W)

Faculty of Medicine, Technion, Israel institute of Medicine, Haifa, Israel; Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH